Cardax, Inc.
CDXI · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $2 | $1 |
| % Growth | -24.2% | -52.9% | 147.6% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 63.6% | 51.4% | 53.7% | 55% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $4 | $5 | $1 |
| SG&A Expenses | $3 | $4 | $5 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $4 | $5 | $2 |
| Operating Income | -$3 | -$4 | -$4 | -$2 |
| % Margin | -568.3% | -573.5% | -266.2% | -328.1% |
| Other Income/Exp. Net | -$2 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$5 | -$5 | -$4 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$5 | -$4 | -$2 |
| % Margin | -938% | -716.4% | -266.4% | -325.3% |
| EPS | -6.79 | -8.4 | -6.32 | -3.97 |
| % Growth | 19.2% | -32.9% | -59.2% | – |
| EPS Diluted | -6.79 | -8.4 | -6.32 | -3.97 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$4 | -$4 | -$2 |
| % Margin | -489.2% | -623.1% | -264.3% | -323.3% |